Detalles de la búsqueda
1.
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial.
Cancer Immunol Immunother
; 69(3): 477-488, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980913
2.
Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology.
Haematologica
; 100(5): 677-82, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661441
3.
Evaluation of Dutch guideline for just-in-time addition of plerixafor to stem cell mobilization in patients who fail with granulocyte-colony-stimulating factor.
Transfusion
; 55(5): 1021-7, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25641128
4.
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
J Clin Oncol
; 39(32): 3613-3622, 2021 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520219
5.
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.
J Immunother Cancer
; 7(1): 302, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727154
6.
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
Haematologica
; 92(7): 928-35, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17606443
7.
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
N Engl J Med
; 358(1): 92; author reply 92-3, 2008 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-18172953
8.
Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
Cancer Res
; 73(1): 19-29, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23087058
9.
Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients.
Clin Cancer Res
; 18(19): 5460-70, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22896657
10.
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.
Blood
; 101(6): 2144-51, 2003 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12456509
Resultados
1 -
10
de 10
1
Próxima >
>>